McClellan Cites OTC Relief For States With Tightened Budget Belts
This article was originally published in The Tan Sheet
Executive Summary
FDA Commissioner Mark McClellan, MD/PhD, highlighted the cost-effectiveness of OTC drugs in reducing pricing pressures on the healthcare system at an Academy Health/Health Affairs National Health Policy Conference Jan. 28
You may also be interested in...
McClellan Touts Role Of Pharmacists In Promoting OTCs As Cost Savers
Centers for Medicare & Medicaid Services Administrator Mark McClellan is calling on pharmacists to encourage the use of OTC alternatives to higher priced prescription drugs "when appropriate.
McClellan Touts Role Of Pharmacists In Promoting OTCs As Cost Savers
Centers for Medicare & Medicaid Services Administrator Mark McClellan is calling on pharmacists to encourage the use of OTC alternatives to higher priced prescription drugs "when appropriate.
McClellan Touts Role Of Pharmacists In Promoting OTCs As Cost Savers
Centers for Medicare & Medicaid Services Administrator Mark McClellan is calling on pharmacists to encourage the use of OTC alternatives to higher priced prescription drugs "when appropriate.